Market Cap : 8.02 B | Enterprise Value : 6.73 B | PE Ratio : 119.51 | PB Ratio : 5.80 |
---|
NAS:IONS has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IONS has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Ionis Pharmaceuticals's Accumulated other comprehensive income (loss) for the quarter that ended in Sep. 2020 was $-19.6 Mil.
Ionis Pharmaceuticals's quarterly Accumulated other comprehensive income (loss) increased from Mar. 2020 ($-27.2 Mil) to Jun. 2020 ($-16.4 Mil) but then declined from Jun. 2020 ($-16.4 Mil) to Sep. 2020 ($-19.6 Mil).
Ionis Pharmaceuticals's annual Accumulated other comprehensive income (loss) declined from Dec. 2017 ($-31.8 Mil) to Dec. 2018 ($-32.0 Mil) but then increased from Dec. 2018 ($-32.0 Mil) to Dec. 2019 ($-25.3 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.
No Headline